February 26, 2022 Comments Off on New patent for Msd Merck drug DELSTRIGO Posted in: Patent Added Annual Drug Patent Expirations for DELSTRIGO Delstrigo is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Msd Merck drug DELSTRIGO appeared first on DrugPatentWatch…
February 26, 2022 Comments Off on New patent for Amgen Inc drug LUMAKRAS Posted in: Patent Added Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentW…
